Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy

Published:2022-04 Issue: Volume:50 Page:102260
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Liu Lei,Bai Fang,Song Hui,Xiao Rong,Wang Yuzhen,Yang Huimin,Ren Xiaolei,Li Shuangjie,Gao Lifen,Ma Chunhong,Yang Xiangdong,Liang Xiaohong

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference48 articles.

1. Update on diabetic nephropathy: Core curriculum 2018;Umanath;Am. J. Kidney Dis.,2018

2. Non-genetic mechanisms of diabetic nephropathy;Han;Front. Med.,2017

3. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies;Warren;Expert Opin. Ther. Targets,2019

4. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis;Neuen;Lancet Diabetes Endocrinol.,2019

5. ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal disease;Perico;Curr. Opin. Pharmacol.,2017

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2;Phytomedicine;2024-11

2. Renal tubular epithelial cells response to injury in acute kidney injury;eBioMedicine;2024-09

3. Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy;Diabetes Therapy;2024-08-21

4. Renal tubular epithelial cell quality control mechanisms as therapeutic targets in renal fibrosis;Journal of Pharmaceutical Analysis;2024-08

5. TIPE1 limits virus replication by disrupting PKM2/ HIF-1α/ glycolysis feedback loop;Free Radical Biology and Medicine;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3